img

Global Insomnia Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Insomnia Medication Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Insomnia Medication report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Insomnia Medication market is projected to reach US$ 3710.3 million in 2034, increasing from US$ 2921.6 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Adults and Kids are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Insomnia Medication industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Insomnia Medication key manufacturers include Eisai, Merck, Pfizer, Sanofi, Takeda, Vanda Pharmaceuticals, Astellas, Dainippon Sumitomo and ECR Pharmaceuticals (Valeant), etc. Eisai, Merck, Pfizer are top 3 players and held % sales share in total in 2022.
Insomnia Medication can be divided into Nonbenzodiazepine Receptor Agonists, Benzodiazepine Receptor Agonists, The Selective Melatonin Receptor Agonist Ramelteon and Sedating Antidepressants, etc. Nonbenzodiazepine Receptor Agonists is the mainstream product in the market, accounting for % sales share globally in 2022.
Insomnia Medication is widely used in various fields, such as Adults and Kids, etc. Adults provides greatest supports to the Insomnia Medication industry development. In 2022, global % sales of Insomnia Medication went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Insomnia Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Segment by Type
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants

Segment by Application


Adults
Kids

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Insomnia Medication market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Insomnia Medication, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Insomnia Medication industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Insomnia Medication in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Insomnia Medication introduction, etc. Insomnia Medication Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Insomnia Medication market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Insomnia Medication Market Overview
1.1 Insomnia Medication Product Overview
1.2 Insomnia Medication Market Segment by Type
1.2.1 Nonbenzodiazepine Receptor Agonists
1.2.2 Benzodiazepine Receptor Agonists
1.2.3 The Selective Melatonin Receptor Agonist Ramelteon
1.2.4 Sedating Antidepressants
1.3 Global Insomnia Medication Market Size by Type
1.3.1 Global Insomnia Medication Market Size Overview by Type (2018-2034)
1.3.2 Global Insomnia Medication Historic Market Size Review by Type (2018-2024)
1.3.3 Global Insomnia Medication Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insomnia Medication Sales Breakdown by Type (2018-2024)
1.4.2 Europe Insomnia Medication Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Insomnia Medication Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Insomnia Medication Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Insomnia Medication Sales Breakdown by Type (2018-2024)
2 Global Insomnia Medication Market Competition by Company
2.1 Global Top Players by Insomnia Medication Sales (2018-2024)
2.2 Global Top Players by Insomnia Medication Revenue (2018-2024)
2.3 Global Top Players by Insomnia Medication Price (2018-2024)
2.4 Global Top Manufacturers Insomnia Medication Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insomnia Medication Market Competitive Situation and Trends
2.5.1 Insomnia Medication Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Insomnia Medication Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
2.7 Date of Key Manufacturers Enter into Insomnia Medication Market
2.8 Key Manufacturers Insomnia Medication Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insomnia Medication Status and Outlook by Region
3.1 Global Insomnia Medication Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Insomnia Medication Historic Market Size by Region
3.2.1 Global Insomnia Medication Sales in Volume by Region (2018-2024)
3.2.2 Global Insomnia Medication Sales in Value by Region (2018-2024)
3.2.3 Global Insomnia Medication Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Insomnia Medication Forecasted Market Size by Region
3.3.1 Global Insomnia Medication Sales in Volume by Region (2024-2034)
3.3.2 Global Insomnia Medication Sales in Value by Region (2024-2034)
3.3.3 Global Insomnia Medication Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Insomnia Medication by Application
4.1 Insomnia Medication Market Segment by Application
4.1.1 Adults
4.1.2 Kids
4.2 Global Insomnia Medication Market Size by Application
4.2.1 Global Insomnia Medication Market Size Overview by Application (2018-2034)
4.2.2 Global Insomnia Medication Historic Market Size Review by Application (2018-2024)
4.2.3 Global Insomnia Medication Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insomnia Medication Sales Breakdown by Application (2018-2024)
4.3.2 Europe Insomnia Medication Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Insomnia Medication Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Insomnia Medication Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Insomnia Medication Sales Breakdown by Application (2018-2024)
5 North America Insomnia Medication by Country
5.1 North America Insomnia Medication Historic Market Size by Country
5.1.1 North America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Insomnia Medication Sales in Volume by Country (2018-2024)
5.1.3 North America Insomnia Medication Sales in Value by Country (2018-2024)
5.2 North America Insomnia Medication Forecasted Market Size by Country
5.2.1 North America Insomnia Medication Sales in Volume by Country (2024-2034)
5.2.2 North America Insomnia Medication Sales in Value by Country (2024-2034)
6 Europe Insomnia Medication by Country
6.1 Europe Insomnia Medication Historic Market Size by Country
6.1.1 Europe Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Insomnia Medication Sales in Volume by Country (2018-2024)
6.1.3 Europe Insomnia Medication Sales in Value by Country (2018-2024)
6.2 Europe Insomnia Medication Forecasted Market Size by Country
6.2.1 Europe Insomnia Medication Sales in Volume by Country (2024-2034)
6.2.2 Europe Insomnia Medication Sales in Value by Country (2024-2034)
7 Asia-Pacific Insomnia Medication by Region
7.1 Asia-Pacific Insomnia Medication Historic Market Size by Region
7.1.1 Asia-Pacific Insomnia Medication Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Insomnia Medication Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Insomnia Medication Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Insomnia Medication Forecasted Market Size by Region
7.2.1 Asia-Pacific Insomnia Medication Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Insomnia Medication Sales in Value by Region (2024-2034)
8 Latin America Insomnia Medication by Country
8.1 Latin America Insomnia Medication Historic Market Size by Country
8.1.1 Latin America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Insomnia Medication Sales in Volume by Country (2018-2024)
8.1.3 Latin America Insomnia Medication Sales in Value by Country (2018-2024)
8.2 Latin America Insomnia Medication Forecasted Market Size by Country
8.2.1 Latin America Insomnia Medication Sales in Volume by Country (2024-2034)
8.2.2 Latin America Insomnia Medication Sales in Value by Country (2024-2034)
9 Middle East and Africa Insomnia Medication by Country
9.1 Middle East and Africa Insomnia Medication Historic Market Size by Country
9.1.1 Middle East and Africa Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Insomnia Medication Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Insomnia Medication Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Insomnia Medication Forecasted Market Size by Country
9.2.1 Middle East and Africa Insomnia Medication Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Insomnia Medication Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Eisai
10.1.1 Eisai Company Information
10.1.2 Eisai Introduction and Business Overview
10.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Eisai Insomnia Medication Products Offered
10.1.5 Eisai Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Insomnia Medication Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Insomnia Medication Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi Insomnia Medication Products Offered
10.4.5 Sanofi Recent Development
10.5 Takeda
10.5.1 Takeda Company Information
10.5.2 Takeda Introduction and Business Overview
10.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Takeda Insomnia Medication Products Offered
10.5.5 Takeda Recent Development
10.6 Vanda Pharmaceuticals
10.6.1 Vanda Pharmaceuticals Company Information
10.6.2 Vanda Pharmaceuticals Introduction and Business Overview
10.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Vanda Pharmaceuticals Insomnia Medication Products Offered
10.6.5 Vanda Pharmaceuticals Recent Development
10.7 Astellas
10.7.1 Astellas Company Information
10.7.2 Astellas Introduction and Business Overview
10.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Astellas Insomnia Medication Products Offered
10.7.5 Astellas Recent Development
10.8 Dainippon Sumitomo
10.8.1 Dainippon Sumitomo Company Information
10.8.2 Dainippon Sumitomo Introduction and Business Overview
10.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Dainippon Sumitomo Insomnia Medication Products Offered
10.8.5 Dainippon Sumitomo Recent Development
10.9 ECR Pharmaceuticals (Valeant)
10.9.1 ECR Pharmaceuticals (Valeant) Company Information
10.9.2 ECR Pharmaceuticals (Valeant) Introduction and Business Overview
10.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products Offered
10.9.5 ECR Pharmaceuticals (Valeant) Recent Development
10.10 Flynn Pharma
10.10.1 Flynn Pharma Company Information
10.10.2 Flynn Pharma Introduction and Business Overview
10.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Flynn Pharma Insomnia Medication Products Offered
10.10.5 Flynn Pharma Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Johnson & Johnson Insomnia Medication Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Meda
10.12.1 Meda Company Information
10.12.2 Meda Introduction and Business Overview
10.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Meda Insomnia Medication Products Offered
10.12.5 Meda Recent Development
10.13 Somnus Therapeutics
10.13.1 Somnus Therapeutics Company Information
10.13.2 Somnus Therapeutics Introduction and Business Overview
10.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Somnus Therapeutics Insomnia Medication Products Offered
10.13.5 Somnus Therapeutics Recent Development
10.14 Purdue Pharma
10.14.1 Purdue Pharma Company Information
10.14.2 Purdue Pharma Introduction and Business Overview
10.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Purdue Pharma Insomnia Medication Products Offered
10.14.5 Purdue Pharma Recent Development
10.15 Neurim
10.15.1 Neurim Company Information
10.15.2 Neurim Introduction and Business Overview
10.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Neurim Insomnia Medication Products Offered
10.15.5 Neurim Recent Development
10.16 Minerva Neurosciences
10.16.1 Minerva Neurosciences Company Information
10.16.2 Minerva Neurosciences Introduction and Business Overview
10.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Minerva Neurosciences Insomnia Medication Products Offered
10.16.5 Minerva Neurosciences Recent Development
10.17 Pernix Therapeutics
10.17.1 Pernix Therapeutics Company Information
10.17.2 Pernix Therapeutics Introduction and Business Overview
10.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Pernix Therapeutics Insomnia Medication Products Offered
10.17.5 Pernix Therapeutics Recent Development
10.18 SkyePharma
10.18.1 SkyePharma Company Information
10.18.2 SkyePharma Introduction and Business Overview
10.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.18.4 SkyePharma Insomnia Medication Products Offered
10.18.5 SkyePharma Recent Development
10.19 Paratek Pharmaceuticals
10.19.1 Paratek Pharmaceuticals Company Information
10.19.2 Paratek Pharmaceuticals Introduction and Business Overview
10.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Paratek Pharmaceuticals Insomnia Medication Products Offered
10.19.5 Paratek Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insomnia Medication Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insomnia Medication Industrial Chain Analysis
11.4 Insomnia Medication Market Dynamics
11.4.1 Insomnia Medication Industry Trends
11.4.2 Insomnia Medication Market Drivers
11.4.3 Insomnia Medication Market Challenges
11.4.4 Insomnia Medication Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insomnia Medication Distributors
12.3 Insomnia Medication Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Nonbenzodiazepine Receptor Agonists
Table 2. Major Company of Benzodiazepine Receptor Agonists
Table 3. Major Company of The Selective Melatonin Receptor Agonist Ramelteon
Table 4. Major Company of Sedating Antidepressants
Table 5. Global Insomnia Medication Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Insomnia Medication Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Insomnia Medication Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Insomnia Medication Sales by Type (2018-2024) & (US& Million)
Table 9. Global Insomnia Medication Market Share in Value by Type (2018-2024)
Table 10. Global Insomnia Medication Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Insomnia Medication Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Insomnia Medication Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Insomnia Medication Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Insomnia Medication Sales Market Share in Value by Type (2024-2034)
Table 15. Global Insomnia Medication Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Insomnia Medication Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Insomnia Medication Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Insomnia Medication Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Insomnia Medication Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Insomnia Medication Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Insomnia Medication Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Insomnia Medication Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Insomnia Medication Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Insomnia Medication Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Insomnia Medication Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Insomnia Medication Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Insomnia Medication Sales Share by Company (2018-2024)
Table 28. Global Insomnia Medication Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Insomnia Medication Revenue Share by Company (2018-2024)
Table 30. Global Market Insomnia Medication Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Insomnia Medication Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insomnia Medication as of 2022)
Table 34. Date of Key Manufacturers Enter into Insomnia Medication Market
Table 35. Key Manufacturers Insomnia Medication Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Insomnia Medication Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Insomnia Medication Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Insomnia Medication Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Insomnia Medication Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Insomnia Medication Sales Market Share in Value by Region (2018-2024)
Table 42. Global Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Insomnia Medication Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Insomnia Medication Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Insomnia Medication Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Insomnia Medication Sales Market Share in Value by Region (2024-2034)
Table 47. Global Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Insomnia Medication Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Insomnia Medication Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Insomnia Medication Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Insomnia Medication Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Insomnia Medication Sales Market Share in Value by Application (2018-2024)
Table 53. Global Insomnia Medication Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Insomnia Medication Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Insomnia Medication Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Insomnia Medication Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Insomnia Medication Sales Market Share in Value by Application (2024-2034)
Table 58. Global Insomnia Medication Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Insomnia Medication Sales by Application (2018-2024) (K Pcs)
Table 60. North America Insomnia Medication Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Insomnia Medication Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Insomnia Medication Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Insomnia Medication Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Insomnia Medication Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Insomnia Medication Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Insomnia Medication Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Insomnia Medication Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Insomnia Medication Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Insomnia Medication Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Insomnia Medication Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Insomnia Medication Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Insomnia Medication Sales Market Share in Value by Country (2018-2024)
Table 73. North America Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Insomnia Medication Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Insomnia Medication Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Insomnia Medication Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Insomnia Medication Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Insomnia Medication Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Insomnia Medication Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Insomnia Medication Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Insomnia Medication Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Insomnia Medication Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Insomnia Medication Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Insomnia Medication Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Insomnia Medication Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Insomnia Medication Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Insomnia Medication Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Insomnia Medication Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Insomnia Medication Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Insomnia Medication Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Insomnia Medication Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Insomnia Medication Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Insomnia Medication Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Insomnia Medication Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Insomnia Medication Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Insomnia Medication Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Insomnia Medication Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Insomnia Medication Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Insomnia Medication Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Insomnia Medication Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Insomnia Medication Sales Market Share in Value by Country (2024-2034)
Table 109. Eisai Company Information
Table 110. Eisai Introduction and Business Overview
Table 111. Eisai Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Eisai Insomnia Medication Product
Table 113. Eisai Recent Development
Table 114. Merck Company Information
Table 115. Merck Introduction and Business Overview
Table 116. Merck Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Merck Insomnia Medication Product
Table 118. Merck Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Pfizer Insomnia Medication Product
Table 123. Pfizer Recent Development
Table 124. Sanofi Company Information
Table 125. Sanofi Introduction and Business Overview
Table 126. Sanofi Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Sanofi Insomnia Medication Product
Table 128. Sanofi Recent Development
Table 129. Takeda Company Information
Table 130. Takeda Introduction and Business Overview
Table 131. Takeda Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Takeda Insomnia Medication Product
Table 133. Takeda Recent Development
Table 134. Vanda Pharmaceuticals Company Information
Table 135. Vanda Pharmaceuticals Introduction and Business Overview
Table 136. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Vanda Pharmaceuticals Insomnia Medication Product
Table 138. Vanda Pharmaceuticals Recent Development
Table 139. Astellas Company Information
Table 140. Astellas Introduction and Business Overview
Table 141. Astellas Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Astellas Insomnia Medication Product
Table 143. Astellas Recent Development
Table 144. Dainippon Sumitomo Company Information
Table 145. Dainippon Sumitomo Introduction and Business Overview
Table 146. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Dainippon Sumitomo Insomnia Medication Product
Table 148. Dainippon Sumitomo Recent Development
Table 149. ECR Pharmaceuticals (Valeant) Company Information
Table 150. ECR Pharmaceuticals (Valeant) Introduction and Business Overview
Table 151. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. ECR Pharmaceuticals (Valeant) Insomnia Medication Product
Table 153. ECR Pharmaceuticals (Valeant) Recent Development
Table 154. Flynn Pharma Company Information
Table 155. Flynn Pharma Introduction and Business Overview
Table 156. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. Flynn Pharma Insomnia Medication Product
Table 158. Flynn Pharma Recent Development
Table 159. Johnson & Johnson Company Information
Table 160. Johnson & Johnson Introduction and Business Overview
Table 161. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Johnson & Johnson Insomnia Medication Product
Table 163. Johnson & Johnson Recent Development
Table 164. Meda Company Information
Table 165. Meda Introduction and Business Overview
Table 166. Meda Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 167. Meda Insomnia Medication Product
Table 168. Meda Recent Development
Table 169. Somnus Therapeutics Company Information
Table 170. Somnus Therapeutics Introduction and Business Overview
Table 171. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 172. Somnus Therapeutics Insomnia Medication Product
Table 173. Somnus Therapeutics Recent Development
Table 174. Purdue Pharma Company Information
Table 175. Purdue Pharma Introduction and Business Overview
Table 176. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 177. Purdue Pharma Insomnia Medication Product
Table 178. Purdue Pharma Recent Development
Table 179. Neurim Company Information
Table 180. Neurim Introduction and Business Overview
Table 181. Neurim Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 182. Neurim Insomnia Medication Product
Table 183. Neurim Recent Development
Table 184. Minerva Neurosciences Company Information
Table 185. Minerva Neurosciences Introduction and Business Overview
Table 186. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 187. Minerva Neurosciences Insomnia Medication Product
Table 188. Minerva Neurosciences Recent Development
Table 189. Pernix Therapeutics Company Information
Table 190. Pernix Therapeutics Introduction and Business Overview
Table 191. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 192. Pernix Therapeutics Insomnia Medication Product
Table 193. Pernix Therapeutics Recent Development
Table 194. SkyePharma Company Information
Table 195. SkyePharma Introduction and Business Overview
Table 196. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 197. SkyePharma Insomnia Medication Product
Table 198. SkyePharma Recent Development
Table 199. Paratek Pharmaceuticals Company Information
Table 200. Paratek Pharmaceuticals Introduction and Business Overview
Table 201. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 202. Paratek Pharmaceuticals Insomnia Medication Product
Table 203. Paratek Pharmaceuticals Recent Development
Table 204. Key Raw Materials Lists
Table 205. Raw Materials Key Suppliers Lists
Table 206. Insomnia Medication Market Trends
Table 207. Insomnia Medication Market Drivers
Table 208. Insomnia Medication Market Challenges
Table 209. Insomnia Medication Market Restraints
Table 210. Insomnia Medication Distributors List
Table 211. Insomnia Medication Downstream Customers
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Insomnia Medication Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Insomnia Medication Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Nonbenzodiazepine Receptor Agonists
Figure 6. Global Nonbenzodiazepine Receptor Agonists Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Benzodiazepine Receptor Agonists
Figure 8. Global Benzodiazepine Receptor Agonists Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of The Selective Melatonin Receptor Agonist Ramelteon
Figure 10. Global The Selective Melatonin Receptor Agonist Ramelteon Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Sedating Antidepressants
Figure 12. Global Sedating Antidepressants Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Insomnia Medication Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Insomnia Medication Sales Market Share by Type in 2022 & 2034
Figure 15. North America Insomnia Medication Sales Market Share in Volume by Type in 2022
Figure 16. North America Insomnia Medication Sales Market Share in Value by Type in 2022
Figure 17. Europe Insomnia Medication Sales Market Share in Volume by Type in 2022
Figure 18. Europe Insomnia Medication Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Insomnia Medication Sales Market Share in Value by Type in 2022
Figure 21. Latin America Insomnia Medication Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Insomnia Medication Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Insomnia Medication Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Revenue in 2022
Figure 27. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Adults
Figure 29. Global Adults Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Kids
Figure 31. Global Kids Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Global Insomnia Medication Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Insomnia Medication Sales Market Share by Application in 2022 & 2034
Figure 34. North America Insomnia Medication Sales Market Share in Volume by Application in 2022
Figure 35. North America Insomnia Medication Sales Market Share in Value by Application in 2022
Figure 36. Europe Insomnia Medication Sales Market Share in Volume by Application in 2022
Figure 37. Europe Insomnia Medication Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Insomnia Medication Sales Market Share in Value by Application in 2022
Figure 40. Latin America Insomnia Medication Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Insomnia Medication Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Insomnia Medication Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Insomnia Medication Manufacturing Cost Structure
Figure 45. Insomnia Medication Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed